P

Pharming Group NV
D

PHAR

7.40000
USD
-0.52
(-6.57%)
Market Closed
Volume
0
EPS
-0
Div Yield
-
P/E
-27
Market Cap
501,982,204
News

Title: Pharming Group NV

Sector: Healthcare
Industry: Biotechnology
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.